Concepedia

Jaime Rubin

JR

16

Publications

1.1K

Citations

15

H-Index

2010

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Harvard University

Pfizer (United States)

Rainbow Babies & Children's Hospital

Case Western Reserve University

Jaime Rubin is an author at Vertex Pharmaceuticals (United States) specializing in medicine, health economics, and epidemiology.

ORCID

Top concepts

Publications per year

2010–2024

16

Publications

16

Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study

Michael W. Konstan, Edward F. McKone, Richard B. Moss et al. · The Lancet Respiratory Medicine · 2016 · 280 citations

, , +1

Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del

Andrea Lopez, Conor Daly, G. Vega-Hernández et al. · Journal of Cystic Fibrosis · 2023 · 126 citations · Full text

Economic model of a birth cohort screening program for hepatitis C virus

Lisa J. McGarry, Vivek Pawar, H. Panchmatia et al. · Hepatology · 2011 · 112 citations · Full text

Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States

Jaime Rubin, Lisa J. McGarry, David Strutton et al. · Vaccine · 2010 · 102 citations

, , +9

Cost Estimation of Cardiovascular Disease Events in the US

Amy K. O’Sullivan, Jaime Rubin, Joshua Nyambose et al. · PharmacoEconomics · 2011 · 86 citations

, , +5

Rows per page

1–5 of 16